These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 2359688

  • 1. Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder.
    Wolraich ML, Lindgren S, Stromquist A, Milich R, Davis C, Watson D.
    Pediatrics; 1990 Jul; 86(1):95-101. PubMed ID: 2359688
    [Abstract] [Full Text] [Related]

  • 2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM, Earls MF.
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [Abstract] [Full Text] [Related]

  • 3. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities.
    Jensen PS, Kettle L, Roper MT, Sloan MT, Dulcan MK, Hoven C, Bird HR, Bauermeister JJ, Payne JD.
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):797-804. PubMed ID: 10405496
    [Abstract] [Full Text] [Related]

  • 4. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P, Hsu HY, Chiou SS, Chao MC.
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [Abstract] [Full Text] [Related]

  • 5. The management of patients with attention-deficit hyperactivity disorder by family practitioners.
    Eppright TD, Bradley S, Vogel SJ, Williamson HA.
    Mo Med; 1998 Mar; 95(3):118-22. PubMed ID: 9529896
    [Abstract] [Full Text] [Related]

  • 6. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2005 Sep 02; 54(34):842-7. PubMed ID: 16138075
    [Abstract] [Full Text] [Related]

  • 7. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov 02; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 8. Pediatricians' reported practices in the assessment and treatment of attention deficit disorders.
    Copeland L, Wolraich M, Lindgren S, Milich R, Woolson R.
    J Dev Behav Pediatr; 1987 Aug 02; 8(4):191-7. PubMed ID: 3611359
    [Abstract] [Full Text] [Related]

  • 9. Management of attention deficit hyperactivity disorder: a parental perspective.
    Concannon PE, Tang YP.
    J Paediatr Child Health; 2005 Dec 02; 41(12):625-30. PubMed ID: 16398864
    [Abstract] [Full Text] [Related]

  • 10. Attention-deficit/hyperactivity disorder.
    Shaywitz BA, Fletcher JM, Shaywitz SE.
    Adv Pediatr; 1997 Dec 02; 44():331-67. PubMed ID: 9265975
    [Abstract] [Full Text] [Related]

  • 11. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS, Guilleminault C, Li HY, Yang CM, Wu YY, Chen NH.
    Sleep Med; 2007 Jan 02; 8(1):18-30. PubMed ID: 17157069
    [Abstract] [Full Text] [Related]

  • 12. Diagnosing childhood attention-deficit/hyperactivity disorder. Do family practitioners and pediatricians make the same call?
    Evink B, Crouse BJ, Elliott BA.
    Minn Med; 2000 Jun 02; 83(6):57-62. PubMed ID: 10881576
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
    Mohammadi MR, Kashani L, Akhondzadeh S, Izadian ES, Ohadinia S.
    J Clin Pharm Ther; 2004 Apr 02; 29(2):139-44. PubMed ID: 15068402
    [Abstract] [Full Text] [Related]

  • 14. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C, Boidein F.
    Encephale; 2001 Apr 02; 27(5):435-43. PubMed ID: 11760693
    [Abstract] [Full Text] [Related]

  • 15. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.
    Child Care Health Dev; 2006 Sep 02; 32(5):575-83. PubMed ID: 16919137
    [Abstract] [Full Text] [Related]

  • 16. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
    Kariyawasam SH, Zaw F, Handley SL.
    Neuro Endocrinol Lett; 2002 Feb 02; 23(1):45-8. PubMed ID: 11880861
    [Abstract] [Full Text] [Related]

  • 17. [A pilot study of methylphenidate and parent training in the treatment of children with attention-deficit hiperactivity disorder].
    Montiel Nava C, Peña JA, Espina Mariñes G, Ferrer-Hernandez ME, López-Rubio A, Puertas-Sánchez S, Cardozo-Durán JJ.
    Rev Neurol; 2002 Feb 02; 35(3):201-5. PubMed ID: 12235578
    [Abstract] [Full Text] [Related]

  • 18. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children.
    Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS.
    Arch Pediatr Adolesc Med; 2007 Sep 02; 161(9):857-64. PubMed ID: 17768285
    [Abstract] [Full Text] [Related]

  • 19. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN, Lesesne CA, Perou R.
    Pediatrics; 2007 Feb 02; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 2007 Feb 02; 16(2):1-37. PubMed ID: 10868163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.